神经科医生和ALS患者的母亲将FDA推向NurOwn批准, Neurologist and ALS patient's mother push FDA for NurOwn approval, citing improved patient outcomes.

一名神经科医生和一名ALS病人的母亲正在倡导林业发展局批准NurOwn,这是可能治疗ALS的一种治疗方法。 A neurologist and the mother of an ALS patient are advocating for the FDA to approve NurOwn, a potential treatment for ALS. 神经科医生注意到病人有了重大改善,包括功能和存活率提高。 The neurologist observed significant improvements in patients, including increased functionality and survival rates. 母亲在ALS失去儿子后,根据真实世界的证据和数据,申请加速批准。 The mother, who lost her son to ALS, has filed a petition for accelerated approval based on real-world evidence and data. 他们敦促林业发展局考虑这一证据,以可能帮助数千名ALS病人。 They urge the FDA to consider this evidence to potentially help thousands of ALS patients.